Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Elderly Men: Toward Better Understanding and Treatment

Drugs and Aging

Volumn 20, Issue 15, 2003, Pages 1111-1125

  Pontari, Michel A ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DOXAZOSIN; FINASTERIDE; GABAPENTIN; NIMESULIDE; OXYBUTYNIN; PENTOSAN POLYSULFATE; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROFECOXIB; SEAPROSE; TAMSULOSIN; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANTICHOLINERGIC EFFECT; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIZZINESS; HUMAN; HYPOTENSION; INFECTION; MENTAL DISEASE; MICROWAVE THERAPY; NEUROLOGIC DISEASE; NEUROMODULATION; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; PATHOGENESIS; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE FLUID; PROSTATITIS; REVIEW; SCORING SYSTEM; SIDE EFFECT; SINUSITIS; SYNCOPE; TACHYCARDIA; TREATMENT OUTCOME; VALIDATION PROCESS; VERTIGO;

ADRENERGIC ALPHA-ANTAGONISTS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; HUMANS; MALE; PAIN; PROSTATITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0346155815     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320150-00004     Document Type: Review

References (133)

1. Drach GW, Fair WR, Meares EM, et al. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? [letter]. J Urol 1978; 120 (2): 266
2. Krieger JN, Nyberg Jr L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282 (3): 236-7
3. de la Rosette JJ, Hubregtse MR, Meuleman EJ, et al. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993; 41 (4): 301-7
4. Krieger J, Jacobs RR, Ross SO. Does the chronic prostatitis/ pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol 2000; 164: 1554-8
5. Krieger JN, Egan KJ, Ross SO, et al. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology 1996; 48 (5): 715-21
6. Schaeffer AJ, Landis JR, Knauss JS, et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol 2002; 168 (2): 593-8
7. Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002; 167: 1363-6
8. Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County study of urinary symptoms and health status among men. Urology 1998; 51: 578-84
9. Nickel CJ, Downey J, Hunter D, et al. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001; 165: 842-5
10. Roberts RO, Jacobson DJ, Girman CJ, et al. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol 2002; 168: 2467-71
11. Collins MM, Stafford RS, O'Leary MP, et al. How common is prostatitis?: a national survey of physician visits. J Urol 1998; 159 (4): 1224-8
12. Wenninger K, Heiman JR, Rothman I, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996; 155 (3): 965-8
13. McNaughton Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001; 16 (10): 656-62
14. Ware JE, Kosinski M, Keller SD. A twelve item short form health survey-construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-3
15. Calhoun E, Collins MM, Pontari M, et al. What is the economic impact of chronic prostatitis [abstract]. J Urol 2001; 165 Suppl. 5: 25
16. Weidner W, Schiefer HG, Krauss H, et al. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection 1991; 19 Suppl. 3: S119-25
17. Roberts RO, Lieber MM, Bostwick DG, et al. A review of clinical and pathological prostatitis syndromes. Urology 1997; 49 (6): 809-21
18. Berger RE, Krieger JN, Rothman I, et al. Bacteria in the prostate tissue of men with idiopathic prostatic inflammation. J Urol 1997; 157 (3): 863-5
19. Ponniah S, Arah I, Alexander RB. PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate 2000; 44 (1): 49-54
20. Zermann DH, Ishigooka M, Doggweiler R, et al. Neurourological insights into the etiology of genitourinary pain in men. J Urol 1999; 161 (3): 903-8
21. Mehik A, Hellstrom P, Sarpola A, et al. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001; 88 (1): 35-8
22. Pontari MA, Litwin MS, O'Leary MP, et al. A case-control study of epidemiological factors in men with chronic pelvic pain syndrome [abstract]. J Urol 2002; 167 Suppl. 4: 24
23. Mehik A, Hellstrom P, Lukkarinen O, et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 2000; 86 (4): 443-8
24. Ohkawa M, Yamaguchi K, Tokunaga S, et al. Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology. Br J Urol 1993; 72 (6): 918-21
25. Doble A, Thomas BJ, Walker MM, et al. The role of Chlamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. J Urol 1989; 141 (2): 332-3
26. Weidner W, Schiefer HG, Brahler E. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 1991; 146 (2): 350-2
27. Weidner W, Schiefer HG, Krauss H. Role of Chlamydia trachomatis and mycoplasmas in chronic prostatitis: a review. Urol Int 1988; 43 (3): 167-73
28. Weidner W, Schiefer HG. Re: Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis [letter]. J Urol 1986; 136 (3): 690
29. Relman D, Schmidt T, MacDermott R, et al. Identidification of the uncultured bacillus of Whipple's Disease. N Engl J Med 1992; 327: 293-301
30. Shoskes DA, Mazurick CA, Landis JR, et al. Bacterial cultures of urine, prostatic fluid and semen of men with chronic pelvic pain syndrome: role of culture for 2 vs 5 days [abstract]. J Urol 2000; 163 Suppl. 4: 24
31. Jarvi K, Wang W, Korithoski B, et al. Identification of unusual bacteria in the semen and urine of men with NIH type III prostatitis [abstract]. J Urol 2001; 165 Suppl. 5: 27
32. Shoskes DA, Shahed AR. Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome. Tech Urol 2000; 6 (3): 240-2
33. Hochreiter WW, Duncan JL, Schaeffer AJ. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 2000; 163 (1): 127-30
34. Keay S, Zhang C, Baldwin BR, et al. Polymerase chain reaction amplification of bacterial 16s rRNA genes in prostate biopsies from men without chronic prostatitis. Urology 1999; 53: 487-91
35. Krieger JN, Riley DE, Vesella RL, et al. Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol 2000; 164 (4): 1221-8
36. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170 (3): 818-22
37. Shahed AR, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000; 21 (5): 669-75
38. John H, Barghorn A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 2001; 39: 72-8
39. Schaeffer AJ, Knauss JS, Landis JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168 (3): 1048-53
40. Hochreiter WW, Nadler RB, Koch AE, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000; 56 (6): 1025-9
41. Nadler RB, Koch AE, Calhoun EA, et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000; 164 (1): 214-8
42. Alexander R, Ponniah S, Hasday J, et al. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998; 52: 744-9
43. Ruggieri M, Braverman AS, Pontari MA. Biochemical markers for inflammation and glands that contribute to the semen in patients with chronic prostatitis/chronic pelvic pain syndrome [abstract]. J Urol 2000; 163 Suppl. 4: 26
44. Hochreiter W, Nadler RB, Koch AE. Diagnostic value of serial cytokine changes in expressed prostatic secretions [abstract]. J Urol 2000; 163 Suppl. 4: 24
45. Miller LJ, Fischer KA, Goralnick SJ, et al. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002; 167 (2 Pt 1): 753-6
46. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79: 469-83
47. Pasqualotto FF, Sharma RK, Potts JM, et al. Seminal oxidative stress in patients with chronic prostatitis. Urology 2000; 55 (6): 881-5
48. Siegel S, Paszkiewicz E, Kirkpatrick C, et al. Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001; 166 (5): 1742-5
49. Lowe E, Anand P, Terengh G, et al. Increased nerve growth factor levels in the urinary bladder of women with sensory urgency and interstitial cystitis. Br J Urol 1997; 79: 572-7
50. Anand P. Nerve growth factor regulates nociception in human health and disese. Br J Anaesthesiol 1995; 75: 201-8
51. Horigome K, Bullock E, Johnson E. Effects of nerve growth factor on rat peritoneal mast cells: survival promotion and immediate-early gene induction. J Biol Chem 1994; 269: 2695-702
52. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59 (4): 603-8
53. Pontari M, Maerten SF, Ruggieri MR. Nerve growth factor is elevated in seminal plasma of men with chronic prostatitis/ chronic pelvic pain syndrome (CPPS) [abstract]. J Urol 2002; 167 Suppl. 4: 25
54. Dimitrakov J. Increased nerve growth factor levels in the post-prostatic massage urine of patients with chronic abacterial prostatitis [abstract]. J Urol 2000; 163 Suppl. 4: 25
55. Ku JH, Kim ME, Lee NK, et al. Influence of environmental factors on chronic prostatitis-like symptoms in young men: results of a community-based survey. Urology 2001; 58 (6): 853-8
56. Potts J, Moritz N, Everson D, et al. Chronic abacterial prostatitis: a functional somatic syndrome? [abstract]. J Urol 2001; 165 Suppl. 4: 25
57. Alighiri M, Chottinger S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49 Suppl. 5A: 52-7
58. Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol 1999; 161 (2): 549-52
59. Simon L, Landis J, Erickson D, et al. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997; 49 Suppl. 5A: 64-75
60. Forrest JB, Vo Q. Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology 2001; 57 Suppl. 6A: 26-9
61. Novicki DE, Larson TR, Swanson SK. Interstitial cystitis in men. Urology 1998; 52: 621-4
62. Koziol JA, Clark DC, Gities RF, et al. The natural history of interstitial cystitis: a survey of 374 patients. J Urol 1993; 149 (3): 465-9
63. Berger RE, Miller JE, Rothman I, et al. Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain. J Urol 1998; 159 (1): 83-5
64. Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998; 160 (5): 1663-7
65. Siroky MB, Goldstein I, Krane RJ. Functional voiding disorders in men. J Urol 1981; 126 (2): 200-4
66. Steinkohl WB, Leach GE. Urodynamic findings in interstitial cystitis. Urology 1989; 34 (6): 399-401
67. Mayo ME, Ross SO, Krieger JN. Few patients with "chronic prostatitis" have significant bladder outlet obstruction. Urology 1998; 52 (3): 417-21
68. Schmidt RA, Vapnek JM. Pelvic floor behavior and interstitial cystitis. Semin Urol 1991; 9 (2): 154-9
69. Duncan JL, Schaeffer AJ. Do infectious agents cause interstitial cystitis? Urology 1997; 49 (5A Suppl.): 48-51
70. Keay S, Zhang CO, Baldwin BR, et al. Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies. J Urol 1998; 159 (1): 280-3
71. Potts JM, Ward AM, Rackley RR. Association of chronic urinary symptoms in women and Ureaplasma urealyticum. Urology 2000; 55 (4): 486-9
72. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991; 145 (4): 732-5
73. Jones EG, Harper ME. Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia expiant cultures. Prostate 1992; 20 (2): 133-49
74. Moldwin RM. Similarities between interstitial cystitis and male chronic pelvic pain syndrome. Curr Urol Rep 2002; 3 (4): 313-8
75. Wesselmann U. Interstitial cystitis: a chronic visceral pain syndrome. Urology 2001; 57 (6 Suppl. 1): 32-9
76. Hohenfellner M, Nunes L, Schmidt RA, et al. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992; 147 (3): 587-91
77. Pang X, Marchand J, Sant GR, et al. Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995; 75 (6): 744-50
78. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997; 49 (5A Suppl.): 14-40
79. Spanos C, Pang X, Ligris K, et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 1997; 157 (2): 669-72
80. Feltis JT, Perez-Marrero R, Emerson LE. Increased mast cells of the bladder in suspected cases of interstitial cystitis: a possible disease marker. J Urol 1987; 138 (1): 42-3
81. Kastrup J, Hald T, Larsen S, et al. Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol 1983; 55 (5): 495-500
82. Theoharides TC, Flaris N, Cronin CT, et al. Mast cell activation in sterile bladder and prostate inflammation. Int Arch Allergy Appl Immunol 1990; 92 (3): 281-6
83. Anderson JB, Parivar F, Lee G, et al. The enigma of interstitial cystitis: an autoimmune disease? Br J Urol 1989; 63 (1): 58-63
84. Nickel JC. Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 60: 20-3
85. Litwin MS, McNaughton Collins M, Fowler Jr FJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure: Chronic Prostatitis Collaborative Research Network. J Urol 1999; 162 (2): 369-75
86. Collins MM, O'Leary MP, Calhoun EA, et al. The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol 2001; 166 (5): 1800-3
87. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5 (5): 492-518
88. Nickel JC. The Pre and Post Massage Test (PPMT): a simple screen for prostatitis. Tech Urol 1997; 3 (1): 38-43
89. Ludwig M, Schroeder-Printzen I, Ludecke G, et al. Comparison of expressed prostatic secretions with urine after prostatic massage: a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology 2000; 55 (2): 175-7
90. de la Rosette JJ, Hubregtse MR, Wiersma AM, et al. Value of urine cytology. Acta Cytol 1993; 37: 710-2
91. Nadler RB, Schaeffer A, Knauss JS, et al. Total prostate specific antigen is elevated and statistically, but not clinically significant in patients with chronic pelvic pain syndrome [abstract]. J Urol 2003; 169 Suppl. 4: 27
92. McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000; 133 (5): 367-81
93. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999; 54 (2): 229-33
94. Propert KJ, Alexander RB, Nickel JC, et al. Design of a multicenter randomized clinical trial for chronic prostatitis/ chronic pelvic pain syndrome. Urology 2002; 59 (6): 870-6
95. Bjerklund Johansen TE, Gruneberg RN, Guibert J, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998; 34 (6): 457-66
96. Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001; 165 (5): 1539-44
97. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998; 159 (3): 883-7
98. Osborn DE, George NJ, Rao PN, et al. Prostatodynia: physiological characteristics and rational management with muscle relaxants. Br J Urol 1981; 53 (6): 621-3
99. de la Rosette JJ, Karthaus HF, van Kerrebroeck PE, et al. Research in 'prostatitis syndromes': the use of Alfuzosin (a new alpha-1 receptor blocking agent) in patients mainly presenting with micturition complaints of an irritatvie nature and confirmed urodynamic abnormalities. Eur Urol 1992; 22: 222-7
100. Neal DE, Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology 1994; 43: 460-5
101. Narayan P, McKay J, Doyle C. A six-week double-blind pilot study of Tamsulosin versus placebo in patients with chronic non-bacterial prostatitis/chronic pelvic pain [abstract]. J Urol 2002; 167 Suppl. 4: 24
102. Pfizer. Cardura (doxazosin mesylate) tablets. In: Sifton DW, editor. Physicians' Desk Reference. 55th ed. Montvale (NJ): Medical Economics Company. 2001: 2473-2477
103. Wilde MI, McTavish D. Tamsulosin: a review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs 1996; 52 (6): 883-98
104. Beduschi MC, Beduschi R, Oesterling JE. Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha 1A-adrenergic antagonist. Urology 1998; 51 (6): 861-72
105. Rudner XL, Berkowitz DE, Booth JV, et al. Subtype specific regulation of human vascular alpha (1)-adrenergic receptors by vessel bed and age. Circulation 1999; 100 (23): 2336-43
106. Muraro G. Clinical study on the efficacy and safety of seaprose S combined with local prostate hyperthermia in chronic nonbacterial prostatitis: controlled study versus local prostatic hyperthermia. Archivio di Medicina Interna 1995; 47: 73-86
107. Canale D, Turchi P, Giorgi PM, et al. Treatment of abacterial prostato-vesiculitis with nimesulide. Drugs 1993; 46 Suppl. 1: 147-50
108. Nickel JC, Gittleman M, Malek G, et al. Effects of rofecoxib in patients with chronic nonbacterial prostatitis: a placebo controlled pilot study [abstract]. J Urol 2001; 165 Suppl. 5: 27
109. Appleton I, Tomlinson A, Willoughby DA. Induction of cyclooxygenase and nitric oxide synthase in inflammation. Adv Pharmacol 1996; 35: 27-78
110. Rimarachin JA, Jacobson JA, Szabo P. Regulation of cyclooxygense-2 experssion in aortic smooth muscle cells. Arterioscler Thromb 1994; 14: 1021-31
111. Lacroix S, Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase, enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 1998; 70: 452-66
112. Nickel JC, Pontari M, Moon T, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003; 169 (4): 1401-5
113. Wedren H. Effects of sodium pentosanpolysulphate on symptoms related to chronic non-bacterial prostatitis: a double-blind randomized study. Scand J Urol Nephrol 1987; 21 (2): 81-8
114. Nickel JC, Johnston B, Downey J, et al. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology 2000; 56 (3): 413-7
115. Nickel JC, Forrest J, Tomera KM, et al. Effects of pentosanpolysulfate sodium in men with chronic pelvic pain syndrome: a multicenter randomized placebo controlled study: on behalf of the North American PPS-CPPS Investigator Group [abstract]. J Urol 2002; 167 Suppl. 4: 63
116. Downey J, Nickel JC, Pontari MA, et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: Category IIIA CPPS (Chronic nonbacterial prostatitis) [abstract]. J Urol 2002; 167 Suppl. 4: 26
117. McConnell JD, Bruskewitz RC, Walsh P, et al. The effect of finasteride on the risk of urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998; 338: 557-63
118. McConnell JD, MTOPS Steering Committee. The long term effects of medical therapy on the progression of BPH: Results from the MTOPS trial [abstract]. J Urol 2002; 167 Suppl. 4: 265
119. Shoskes DA, Zeitlin SI, Shared A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54 (6): 960-3
120. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995; 45 (12 Suppl. 9): S17-25
121. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353 (9168): 1959-64
122. Abrams P. Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns [abstract]. J Urol 2002; 167 Suppl. 4: 266
123. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280 (21): 1831-6
124. Sasaki K, Smith CP, Chuang YC, et al. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 2001; 7 (1): 47-9
125. Kaplan SA, Te AE, Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopie incision of the bladder neck. J Urol 1994; 152 (6 Pt 1): 2063-5
126. Servadio C, Leib Z. Chronic abacterial prostatitis and hyperthermia: a possible new treatment? Br J Urol 1991; 67 (3): 308-11
127. Montorsi F, Guazzoni G, Bergamaschi F, et al. Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia? Prostate 1993; 22 (2): 139-46
128. Shah TK, Watson GM, Barnes DG. Microwave hyperthermia in the treatment of chronic abacterial prostatitis and prostatodynia: results of a double-blind placebo controlled trial [abstract]. J Urol 1993; 149 Suppl. 4: 405A
129. Nickel JC, Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J Urol 1996; 155 (6): 1950-4
130. Choi NG, Soh SH, Yoon TH, et al. Clinical experience with transurethral microwave thermotherapy for chronic nonbacterial prostatitis and prostatodynia. J Endourol 1994; 8 (1): 61-4
131. Lee KC, Jung PB, Park HS, et al. Transurethral needle ablation for chronic nonbacterial prostatitis. BJU Int 2002; 89 (3): 226-9
132. Leskinen MJ, Kilponen A, Lukkarinen O, et al. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology 2002; 60 (2): 300-4
133. Clemens JQ, Nadler RB, Schaeffer AJ, et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000; 56 (6): 951-5